Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 2
2017 1
2021 2
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Brown-Frandsen K, Moses A, Skibsted S, Kvist K, Buse JB; DEVOTE Study Group. Marso SP, et al. N Engl J Med. 2017 Aug 24;377(8):723-732. doi: 10.1056/NEJMoa1615692. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605603 Free PMC article. Clinical Trial.
Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection: A Phase 2 Dose-Ranging Randomized Clinical Trial.
Portal-Celhay C, Forleo-Neto E, Eagan W, Musser BJ, Davis JD, Turner KC, Norton T, Hooper AT, Hamilton JD, Pan C, Mahmood A, Baum A, Kyratsous CA, Kim Y, Parrino J, Kampman W, Roque-Guerrero L, Stoici R, Fatakia A, Soo Y, Geba GP, Kowal B, DiCioccio AT, Stahl N, Lipsich L, Braunstein N, Herman GA, Yancopoulos GD, Weinreich DM; COVID-19 Phase 2 Dose-Ranging Study Team. Portal-Celhay C, et al. JAMA Netw Open. 2022 Aug 1;5(8):e2225411. doi: 10.1001/jamanetworkopen.2022.25411. JAMA Netw Open. 2022. PMID: 35969402 Free PMC article. Clinical Trial.
Mapping past human land use using archaeological data: A new classification for global land use synthesis and data harmonization.
Morrison KD, Hammer E, Boles O, Madella M, Whitehouse N, Gaillard MJ, Bates J, Vander Linden M, Merlo S, Yao A, Popova L, Hill AC, Antolin F, Bauer A, Biagetti S, Bishop RR, Buckland P, Cruz P, Dreslerová D, Dusseldorp G, Ellis E, Filipovic D, Foster T, Hannaford MJ, Harrison SP, Hazarika M, Herold H, Hilpert J, Kaplan JO, Kay A, Klein Goldewijk K, Kolář J, Kyazike E, Laabs J, Lancelotti C, Lane P, Lawrence D, Lewis K, Lombardo U, Lucarini G, Arroyo-Kalin M, Marchant R, Mayle F, McClatchie M, McLeester M, Mooney S, Moskal-Del Hoyo M, Navarrete V, Ndiema E, Góes Neves E, Nowak M, Out WA, Petrie C, Phelps LN, Pinke Z, Rostain S, Russell T, Sluyter A, Styring AK, Tamanaha E, Thomas E, Veerasamy S, Welton L, Zanon M. Morrison KD, et al. Among authors: laabs j. PLoS One. 2021 Apr 14;16(4):e0246662. doi: 10.1371/journal.pone.0246662. eCollection 2021. PLoS One. 2021. PMID: 33852578 Free PMC article.
Dye exclusion as a means to measure wetness protection of human skin.
Tate M, Grove G, Joch R, Laabs J, Menard K, Nelson B, Shepard K, Zepp R, Zerweck C, Zuleger R. Tate M, et al. Among authors: laabs j. Skin Res Technol. 2007 Aug;13(3):293-8. doi: 10.1111/j.1600-0846.2007.00227.x. Skin Res Technol. 2007. PMID: 17610651 Clinical Trial.
European Organisation for Research and Treatment of Cancer (EORTC) Pathobiology Group standard operating procedure for the preparation of human tumour tissue extracts suited for the quantitative analysis of tissue-associated biomarkers.
Schmitt M, Mengele K, Schueren E, Sweep FC, Foekens JA, Brünner N, Laabs J, Malik A, Harbeck N; European Organisation for Research and Treatment of Cancer Pathobiology Group. Schmitt M, et al. Among authors: laabs j. Eur J Cancer. 2007 Mar;43(5):835-44. doi: 10.1016/j.ejca.2007.01.008. Epub 2007 Feb 23. Eur J Cancer. 2007. PMID: 17321128